$97.8 Million is the total value of TAM Capital Management Inc.'s 8 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMLP | Exit | ALPS ETF TRalerian mlp | $0 | – | -72,959 | -100.0% | -0.65% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -52,180 | -100.0% | -4.00% | – |
| Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -39,110 | -100.0% | -4.12% | – | |
| TWX | Exit | TIME WARNER INC | $0 | – | -175,506 | -100.0% | -15.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHECK POINT SOFTWARE TECH LT | 12 | Q3 2023 | 96.2% |
| ALTABA INC | 6 | Q3 2018 | 48.5% |
| WILLIAMS COS INC DEL | 5 | Q1 2020 | 42.7% |
| ISHARES TR | 5 | Q3 2018 | 16.5% |
| NXP SEMICONDUCTORS N V | 5 | Q4 2018 | 7.7% |
| FIFTH STR SR FLOATNG RATE CO | 5 | Q4 2015 | 8.9% |
| MEDIWOUND LTD | 5 | Q4 2015 | 0.6% |
| BANK NEW YORK MELLON CORP | 4 | Q3 2023 | 42.7% |
| BOARDWALK PIPELINE PARTNERS | 4 | Q2 2018 | 31.1% |
| SPDR S&P 500 ETF TR | 4 | Q1 2016 | 9.7% |
View TAM Capital Management Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-16 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-15 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-02-13 |
| 13F-HR | 2018-11-14 |
View TAM Capital Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.